Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633

A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia

Hargreaves, K., Dubner, R. A., Brown, F. J., Flores, C., & Joris, J. L. (1988) · Pain · doi:10.1016/0304-3959(88)90026-7 · Cited by 5,155

Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB 1 Receptor Knockout Mice

Ledent, C. A., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Böhme, G. A., Impérato, A., Pedrazzini, T., Roques, B. P., et al. (1999) · Science · doi:10.1126/science.283.5400.401 · Cited by 3,628

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913

2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain

Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

Rinaldi, M. L., Barth, F., Héaulme, M., Shire, D. J., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,762

Leptin-regulated endocannabinoids are involved in maintaining food intake

Di Marzo, V., Goparaju, S. K., Wang, L., Liu, J., Bátkai, S., Járai, Z., Fezza, F., Miura, G. I., Palmiter, R. D., Sugiura, T., et al. (2001) · Nature · doi:10.1038/35071088 · Cited by 1,559

Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

Cravatt, B. F., Demarest, K., Patricelli, M. P., Bracey, M. H., Giang, D. K., Martin, B. R., & Lichtman, A. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161191698 · Cited by 1,310

Modulation of anxiety through blockade of anandamide hydrolysis

Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293

Potential of Endocannabinoids to Control Bladder Pain

Bjorling, D. E., & Wang, Z.-Y. (2018) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2018.00017 · Cited by 24

Association of the c.385C>A (p.Pro129Thr) polymorphism of the fatty acid amide hydrolase gene with anorexia nervosa in the Japanese population

Ando, T., Tamura, N., Mera, T., Morita, C., Takei, M., Nakamoto, C., Koide, M., Hotta, M., Naruo, T., Kawai, K., et al. (2014) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.69 · Cited by 22

Attenuation of serotonin-induced itch responses by inhibition of endocannabinoid degradative enzymes, fatty acid amide hydrolase and monoacylglycerol lipase

Tosun, N. C., Gündüz, Ö., & Ulugöl, A. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1251-x · Cited by 22

A MBP-FAAH fusion protein as a tool to produce human and rat fatty acid amide hydrolase: expression and pharmacological comparison

Labar, G., Vliet, F. V., Wouters, J., & Lambert, D. M. (2007) · Amino Acids · doi:10.1007/s00726-007-0540-1 · Cited by 22

Functional blockage of the cannabinoid receptor type 1 evokes a kappa‐opiate‐dependent analgesia

Sáez-Cassanelli, J. L., Fontanella, G. H., Delgado-Garcia, J. M., & Carrión, Á. M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05000.x · Cited by 22

In vitroandin vivopharmacology of synthetic olivetol‐ or resorcinol‐derived cannabinoid receptor ligands

Cascio, M. G., Bisogno, T., Palazzo, E., Thomas, A., van der Stelt, M., Brizzi, A., de Novellis, V., Marabese, I., Ross, R. A., van de Doelen, T., et al. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706888 · Cited by 22

Long‐term consequences of perinatal fatty acid amino hydrolase inhibition

Wu, C., Morgan, D. J., Jew, C. P., Haskins, C., Andrews, M., Leishman, E., Spencer, C. M., Czyzyk, T. A., Bradshaw, H. B., Mackie, K., et al. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12500 · Cited by 21

Synthesis and Preliminary PET Imaging Studies of a FAAH Radiotracer ([11C]MPPO) Based on α-Ketoheterocyclic Scaffold

Wang, L., Yui, J., Wang, Q., Zhang, Y., Mori, W., Shimoda, Y., Fujinaga, M., Kumata, K., Yamasaki, T., Hatori, A., et al. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00248 · Cited by 21

The monoacylglycerol lipase inhibitor KML29 with gabapentin synergistically produces analgesia in mice

Crowe, M. S., Wilson, C. D., Leishman, E., Prather, P. L., Bradshaw, H. B., Banks, M. L., & Kinsey, S. G. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14055 · Cited by 20

The endocannabinoid and endovanilloid systems and their interactions in neuropathic pain

Maione, S., Starowicz, K., Palazzo, E., Rossi, F., & Marzo, V. D. (2006) · Drug Development Research · doi:10.1002/ddr.20098 · Cited by 21

A Double Whammy: Targeting Both Fatty Acid Amide Hydrolase (FAAH) and Cyclooxygenase (COX) To Treat Pain and Inflammation

Scarpelli, R., Sasso, O., & Piomelli, D. (2015) · ChemMedChem · doi:10.1002/cmdc.201500395 · Cited by 21

Molecular basis of FAAH-OUT -associated human pain insensitivity

Mikaeili, H., Habib, A. M., Yeung, C., Santana‐Varela, S., Luiz, A. P., Panteleeva, K., Zuberi, S. R., Athanasiou‐Fragkouli, A., Houlden, H., Wood, J. N., et al. (2023) · Brain · doi:10.1093/brain/awad098 · Cited by 20

Design, synthesis, and biological evaluation of a series of piperazine ureas as fatty acid amide hydrolase inhibitors

Kono, M., Matsumoto, T., Imaeda, T., Kawamura, T., Fujimoto, S., Kosugi, Y., Odani, T., Shimizu, Y., Matsui, H., Shimojo, M., et al. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.12.023 · Cited by 20

Enhanced microglial activity in FAAH−/− animals

Ativie, F., Albayram, Ö., Bach, K., Pradier, B., Zimmer, A., & Bilkei‐Gorzó, A. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.12.016 · Cited by 20

Visual High-Throughput Screening for Developing a Fatty Acid Amide Hydrolase Natural Inhibitor Based on an Enzyme-Activated Fluorescent Probe

Tian, X., Liu, T., Li, L., Shao, B., Yao, D., Feng, L., Cui, J., James, T. D., & Ma, X. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.9b05826 · Cited by 20

Attenuation of Cystitis and Pain Sensation in Mice Lacking Fatty Acid Amide Hydrolase

Wang, Z., Wang, P., Hillard, C. J., & Bjorling, D. E. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0453-x · Cited by 19

Reduced pain sensitivity in mice lacking latexin, an inhibitor of metallocarboxypeptidases

Jin, M., Ishida, M., Fukui, Y., Tsuchiya, R., Higashinakagawa, T., Ikegami, S., & Arimatsu, Y. (2006) · Brain Research · doi:10.1016/j.brainres.2005.12.099 · Cited by 19

The fatty acid amide hydrolase inhibitor oleoyl ethyl amide counteracts bladder overactivity in female rats

Gandaglia, G., Strittmatter, F., Croce, G. L., Benigni, F., Bettiga, A., Castiglione, F., Moschini, M., Mistretta, F. A., Gratzke, C., Montorsi, F., et al. (2013) · Neurourology and Urodynamics · doi:10.1002/nau.22482 · Cited by 17

2-Amino-5-arylbenzoxazole derivatives as potent inhibitors of fatty acid amide hydrolase (FAAH)

Estiarte, M. A., Johnson, R. J. K., Kaub, C. J., Gowlugari, S., O’Mahony, D. J. R., Nguyen, M. T. L., Emerling, D. E., Kelly, M. G., Kincaid, J., Vincent, F., et al. (2012) · MedChemComm · doi:10.1039/c2md00307d · Cited by 17

Mechanism of Inhibition of Fatty Acid Amide Hydrolase by Sulfonamide-Containing Benzothiazoles: Long Residence Time Derived from Increased Kinetic Barrier and Not Exclusively from Thermodynamic Potency

Tian, G., Paschetto, K. A., Gharahdaghi, F., Gordon, E., Wilkins, D. E., Luo, X., & Scott, C. W. (2011) · Biochemistry · doi:10.1021/bi200552p · Cited by 16

Malonylation of Glucosylated N-Lauroylethanolamine A NEW PATHWAY THAT DETERMINES N-ACYLETHANOLAMINE METABOLIC FATE IN PLANTS

Khan, B. R., Wherritt, D., Huhman, D. V., Sumner, L. W., Chapman, K. D., & Blancaflor, E. B. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.751065 · Cited by 16

Interaction Between the Endocannabinoid and Serotonergic System in the Exhibition of Head Twitch Response in Four Mouse Strains

Ceci, C., Onori, M. P., Macrı̀, S., & Laviola, G. (2014) · Neurotoxicity Research · doi:10.1007/s12640-014-9510-z · Cited by 15

Assessment of dependence potential and abuse liability of Δ8-tetrahydrocannabinol in mice

Vanegas, S. O., Reck, A. M., Rodríguez, C., Marusich, J. A., Yassin, O. A., Sotzing, G. A., Wiley, J. L., & Kinsey, S. G. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109640 · Cited by 15

Fatty Acid Amide Hydrolase (FAAH) Inhibitors Exert Pharmacological Effects, but Lack Antinociceptive Efficacy in Rats with Neuropathic Spinal Cord Injury Pain

Hama, A. T., Germano, P., Varghese, M. S., Cravatt, B. F., Milne, G. T., Pearson, J. P., & Sagen, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096396 · Cited by 15

Arylboronic acids as dual-action FAAH and TRPV1 ligands

Morera, E., Marzo, V. D., Monti, L., Allarà, M., Moriello, A. S., Nalli, M., Ortar, G., & PETROCELLIS, L. D. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.01.071 · Cited by 15

Serum levels of endocannabinoids and related lipids in painful vs painless diabetic neuropathy: results from the Pain in Neuropathy Study

Bäckryd, E., Themistocleous, A. C., Stensson, N., Rice, A. S. C., Tesfaye, S. H., Bennett, D., Gerdle, B. U. C., & Ghafouri, B. (2023) · Pain · doi:10.1097/j.pain.0000000000003015 · Cited by 14

The endogenous cannabinoid anandamide shares discriminative stimulus effects with ∆9-tetrahydrocannabinol in fatty acid amide hydrolase knockout mice

Walentiny, D. M., Gamage, T. F., Warner, J. A., Nguyen, T. K., Grainger, D. B., Wiley, J. L., & Vann, R. E. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.01.056 · Cited by 14

New therapeutic potential for psychoactive natural products

Prevatt‐Smith, K. M., & Prisinzano, T. E. (2009) · Natural Product Reports · doi:10.1039/b912196j · Cited by 14

Molecular Targets of Cannabinoids Associated with Depression

Paudel, P., Ross, S. A., & Li, X. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210623144658 · Cited by 14

Cyclooxygenation of the arachidonoyl side chain of 1-arachidonoylglycerol and related compounds block their ability to prevent anandamide and 2-oleoylglycerol metabolism by rat brain in vitro

Fowler, C. J., & Tiger, G. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.01.016 · Cited by 13

Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice

Walentiny, D. M., Vann, R. E., & Wiley, J. L. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.02.004 · Cited by 11

The Endocannabinoid System as a Target for Neuroprotection/Neuroregeneration in Perinatal Hypoxic–Ischemic Brain Injury

Duranti, A., Beldarrain, G., Alvarez, A. A., Sbriscia, M., Carloni, S., Balduini, W., & Alconada, D. A. (2022) · Biomedicines · doi:10.3390/biomedicines11010028 · Cited by 13

Cannabinoids in chronic non-cancer pain medicine: moving from the bench to the bedside

Meng, H., & Deshpande, A. (2020) · BJA Education · doi:10.1016/j.bjae.2020.05.002 · Cited by 12

The Therapeutic Potential of Drugs that Target Cannabinoid Receptors or Modulate the Tissue Levels or Actions of Endocannabinoids

Pertwee, R. G. (2008) · Springer eBooks · doi:10.1007/978-0-387-76678-2_38 · Cited by 11

Targeting the Cannabinoid System to Produce Analgesia

Sagar, D. R., Jhaveri, M. D., & Chapman, V. (2009) · Current topics in behavioral neurosciences · doi:10.1007/978-3-540-88955-7_11 · Cited by 10

Stable isotope liquid chromatography–tandem mass spectrometry assay for fatty acid amide hydrolase activity

Rakers, C., Zoerner, A. A., Engeli, S., Bátkai, S., Jordan, J., & Tsikas, D. (2011) · Analytical Biochemistry · doi:10.1016/j.ab.2011.11.003 · Cited by 9

Identification of N-acylethanolamines in Dictyostelium discoideum and confirmation of their hydrolysis by fatty acid amide hydrolase

Hayes, A. C., Stupak, J., Li, J., & Cox, A. D. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m032219 · Cited by 9

Correlation of inhibitor effects on enzyme activity and thermal stability for the integral membrane protein fatty acid amide hydrolase

Slaymaker, I. M., Bracey, M. H., Mileni, M., Garfunkle, J., Cravatt, B. F., Boger, D. L., & Stevens, R. C. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.06.086 · Cited by 8

Chapter 4.5 The endocannabinoid system and anxiety responses

Bortolato, M., & Piomelli, D. (2008) · Handbook of Behavioral Neuroscience · doi:10.1016/s1569-7339(07)00014-8 · Cited by 7

Spectroscopic and dynamic properties of arachidonoyl serotonin- β-lactoglobulin complex: A molecular modeling and chemometric study

Gholami, S., Bordbar, A., & Akvan, N. (2016) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2016.07.024 · Cited by 7

Pharmacological characterization of a novel, potent, selective, and orally active fatty acid amide hydrolase inhibitor, PKM‐833 [(R)‐N‐(pyridazin‐3‐yl)‐4‐(7‐(trifluoromethyl)chroman‐4‐yl)piperazine‐1‐carboxamide] in rats: Potential for the treatment of inflammatory pain

Endo, T., Takeuchi, T., & Maehara, S. (2020) · Pharmacology Research & Perspectives · doi:10.1002/prp2.569 · Cited by 6

α-Ketoheterocycle inhibitors of fatty acid amide hydrolase: Exploration of conformational constraints in the acyl side chain

Duncan, K. K., Otrubova, K., & Boger, D. L. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.03.013 · Cited by 8

Inhibition of fatty acid amide hydrolase (FAAH) reduces spinal nociceptive responses and expression of spinal long-term potentiation (LTP)

Eriksen, G. S., Jacobsen, L. M., Mahmood, A., Pedersen, L. M., & Gjerstad, J. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.11.009 · Cited by 7

N-(3,4-Dimethylisoxazol-5-yl)piperazine-4-[4-(2-fluoro-4-[11C]methylphenyl)thiazol-2-yl]-1-carboxamide: A promising positron emission tomography ligand for fatty acid amide hydrolase

Shimoda, Y., Fujinaga, M., Hatori, A., Yui, J., Zhang, Y., Nengaki, N., Kurihara, Y., Yamasaki, T., Xie, L., Kumata, K., et al. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.12.026 · Cited by 7

Animal models of congenital hypoalgesia: Untapped potential for assessing pain-related plasticity

Monteiro, C., Cardoso-Cruz, H., & Galhardo, V. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.11.045 · Cited by 9

Synthesis and preliminary evaluation of a novel positron emission tomography (PET) ligand for imaging fatty acid amide hydrolase (FAAH)

Chen, Z., Hou, L., Gan, J., Cai, Q., Ye, W., Chen, J., Tan, Z., Zheng, C., Li, G., Xu, H., et al. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127513 · Cited by 7

Acetaminophen inhibits diacylglycerol lipase synthesis of 2-arachidonoyl glycerol: Implications for nociception

Dvořáková, M., Bosquez-Berger, T., Billingsley, J., Murataeva, N., Woodward, T. J., Leishman, E., Zimmowitch, A., Gibson, A., Wager‐Miller, J., Cai, R., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102139 · Cited by 6

Association between the FAAH C385A variant (rs324420) and obesity-related traits: a systematic review

Lopez-Cortes, O. D., Trujillo-Sánchez, F., Sierra-Ruelas, É., Martínez‐López, E., Marzo, V. D., & Vizmanos-Lamotte, B. (2023) · International Journal of Obesity · doi:10.1038/s41366-023-01428-9 · Cited by 8

Recent progress in natural product-based inhibitor screening with enzymatic fluorescent probes

Chen, Y. (2021) · Analytical Methods · doi:10.1039/d1ay00245g · Cited by 6

Inhibition of Fatty Acid Amide Hydrolase: A Potential Treatment for Neuropathic Pain: Figure 1.

Trang, T. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0583-07.2007 · Cited by 6

Homology modelling and molecular dynamics study of human fatty acid amide hydrolase

Zhao, Y.-S., Zheng, Q., Zhang, H., Chu, H., & Sun, C. (2009) · Molecular Simulation · doi:10.1080/08927020903033133 · Cited by 6

Imaging and Genetic Tools for the Investigation of the Endocannabinoid System in the CNS

Kouchaeknejad, A., van der Walt, G., de Donato, M. H., & Puighermanal, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115829 · Cited by 6

Chemical proteomics to study metabolism, a reductionist approach applied at the systems level

Ali, M. Y., & Bar‐Peled, L. (2024) · Cell chemical biology · doi:10.1016/j.chembiol.2024.02.015 · Cited by 5

Mechanisms Underlining Inflammatory Pain Sensitivity in Mice Selected for High and Low Stress-Induced Analgesia—The Role of Endocannabinoids and Microglia

Poznański, P., Giebułtowicz, J., Durdzinska, J., Kocki, T., Sacharczuk, M., Bujalska‐Zadrożny, M., & Leśniak, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911686 · Cited by 6

Rapid screening for potentially relevant polymorphisms in the human fatty acid amide hydrolase gene using Pyrosequencing™

Doehring, A., Geißlinger, G., & Lötsch, J. (2007) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2007.06.001 · Cited by 5

Modulation of central endocannabinoid system results in gastric mucosal protection in the rat

Tóth, V. É., Fehér, Á., Németh, J., Gyertyán, I., Zádori, Z., & Gyires, K. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.02.012 · Cited by 4

Novel fatty acid amide hydrolase (FAAH) inhibitors: a patent review from 2015 to 2025

Landolfi, L., Brindisi, M., Onnis, V., Moraca, F., & Catalanotti, B. (2026) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2026.2619515 · Cited by 3

The contribution of baseline circulating endocannabinoids to individual differences in human pain sensitivity: a quantitative sensory testing study

Fatemi, S. A., Abssy, S. S., Bourke, S. L., Murray, K., Kyeremaa-Adjei, C., Honigman, L., Mohabir, N., Sexton, C. A., Cormie, M. A., Tomin, R., et al. (2025) · Pain · doi:10.1097/j.pain.0000000000003850 · Cited by 3

Targeting G protein coupled receptors for alleviating neuropathic pain

Kumari, P., Yadav, A., Patel, M., & Yadav, P. N. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.06.004 · Cited by 3

Lipopolysaccharide-induced pulmonary inflammation is not accompanied by a release of anandamide into the lavage fluid or a down-regulation of the activity of fatty acid amide hydrolase

Holt, S., Rocksén, D., Bucht, A., Petersen, G. L., Hansen, H. S., Valenti, M., Marzo, V. D., & Fowler, C. J. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.09.005 · Cited by 3

Class A GPCRs: Cannabinoid and Opioid Receptor Heteromers

Sierra, S., Gomes, I., & Devi, L. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-60174-8_7 · Cited by 3

Genetic dissection of the endocannabinoid system and how it changed our knowledge of cannabinoid pharmacology and mammalian physiology

Lutz, B. (2014) · Wiley eBooks · doi:10.1002/9781118451281.ch4 · Cited by 3

Glucocorticoid–endocannabinoid crosstalk in the ventrolateral periaqueductal gray (vlPAG) promotes pain resolution

Coutens, B., Bouchet, C. A., Gvon, I., Patti, L. C., Gamboa, C. D. A., Jewett, D. C., Klawitter, J., Klawitter, J., Heinricher, M. M., & Ingram, S. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02529-5 · Cited by 2

Long-Term Tamoxifen Effects in the Cyclic Interaction of the Endocannabinoid and Endocrine System in the Rat Central Nervous System

Fonseca, B. M., Bhowmick, N., Cunha, S. C., Maia, J., Correia‐da‐Silva, G., Teixeira, N. A. A., & Sá, S. I. (2023) · Biomedicines · doi:10.3390/biomedicines11030720 · Cited by 2

PET Molecular Imaging of the Endocannabinoid System in Psychiatric Disorders

Cui, C., Dou, X., Cen, P., Jin, C., Wang, J., Niu, J., Xue, C., Tian, M., Zhang, H., & Zhong, Y. (2025) · Neuroscience Bulletin · doi:10.1007/s12264-025-01515-z · Cited by 2

A Swath Label-Free Proteomics insight into the Faah−/− Mouse Liver

Hamid, Z., Summa, M., & Armirotti, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-30553-z · Cited by 2

Cannabinoid Receptor Mediated Analgesia: Novel Targets for Chronic Pain States

Chapman, V., Kendall, D. A., & Sagar, D. R. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0226-9_15 · Cited by 1

Targeting the Endocannabinoid Metabolic Enzymes to Reduce Inflammatory Pain

Ghosh, S. (2014) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/ngv2-th75 · Cited by 1

Investigating the role of the endogenous cannabinoid system in emotional modulation of pain: neurochemical and molecular mechanisms

Olango, W. M. (2012) · Arrow@dit (Dublin Institute of Technology) · doi:10.13025/17506 · Cited by 1

Control of analgesic and anti-inflammatory pathways by fatty acid amide hydrolase

Long, J. H. (2012) · Cited by 1

Cannabinoid targets for pain therapeutics

Huang, S. M., & Walker, J. M. (2005) · Birkhäuser-Verlag eBooks · doi:10.1007/3-7643-7358-x_8 · Cited by 1

Synthesis and biological evaluation of novel endocannabinoid probes, metabolically stable analogs, and N-acylethanolamine-hydrolyzing acid amidase ihibitors

Whitten, K. M. (2012) · Digital Repository Service (Northeastern University) · doi:10.17760/d20002788 · Cited by 1

Analgesic and Anti-Inflammatory Effects of Monoacylglycerol Lipase Inhibition in Mice Subjected to Collagen-Induced Arthritis

Nass, S. R. (2015) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.6297 · Cited by 1

Molecular Dynamics Analysis of FAAH Complexed with Anandamide

Sousa, S. F., Coimbra, J. T. S., Fernandes, P. A., Marino, T., Ramos, M. J., & Russo, N. (2015) · Progress in theoretical chemistry and physics · doi:10.1007/978-3-319-14397-2_7

Study of the interaction between 3,4 methylenedioximethamphetamine and the endocannabinoid system

Touriño, C. (2009) · Repositori digital de la UPF (Universitat Pompeu Fabra)

Functional Characterization of Plant Fatty Acid Amide Hydrolases

Kim, S. (2010) · University of North Texas Digital Library (University of North Texas) · doi:10.12794/metadc33177

Fatty acid amide hydrolase - A target for anti-inflammatory therapies?

Holt, S. (2005) · KTH Publication Database DiVA (KTH Royal Institute of Technology)

Pharmacology of Palmitoylethanolamide and Related Compounds

Jonsson, K. (2005) · KTH Publication Database DiVA (KTH Royal Institute of Technology)

Removal of Endocannabinoids by the Body: Mechanisms and Therapeutic Possibilities

Fowler, C. J., & Thors, L. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3_3

Changes in endocannabinoid signaling contribute to the anti-hyperalgesic effect of URB597 in a murine model of persistent inflammation.

Lindberg, A. E. (2011) · University of Minnesota Digital Conservancy (University of Minnesota)

Philosophy at Virginia Commonwealth University.

Booker, L. (2011)

Design, synthesis, methodology development, and evaluation of PET imaging agents targeting cancer and CNS disorders

Yuan, G. (2017) · doi:10.17760/d20251581

Short communication Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB 1 receptors

Wise, L. E., Shelton, C. C., Cravatt, B. F., Martin, B. R., & Lichtman, A. H. (2007)

Endocannabinoid metabolism : the impact of inflammatory factors and pharmacological inhibitors

Karlsson, J. (2018) · KTH Publication Database DiVA (KTH Royal Institute of Technology)

Inhibiting the Cannabinoid Catabolic Enzyme MAGL to Potentiate the Anti-Arthritic Properties of the Synthetic Glucocorticoid Dexamethasone

Nass, S. R. (2017) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.6298

Canabinoides

Rice, A. S. C. (2007) · Elsevier eBooks · doi:10.1016/b978-84-8174-949-6.50034-4

Studying the role of endocannabinoid signaling in reproduction

Sun, X. (2010)

Differential roles of the two major endocannabinoid hydrolyzing enzymes in cannabinoid receptor tolerance and somatic withdrawal

Schlosburg, J. E. (2010) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/tss0-g006

Cannabinoids

Rice, A. S. C. (2006) · Elsevier eBooks · doi:10.1016/b0-443-07287-6/50039-4

Faculty Opinions recommendation of Microdeletion in a FAAH pseudogene identified in a patient with high anandamide concentrations and pain insensitivity.

Gallie, D. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735403013.793569977

Regards croisés sur le cannabis

Seutin, V., Scuvée‐Moreau, J., & Quertemont, É. (2010) · Mardaga eBooks · doi:10.3917/mard.seuti.2010.01.0245

The mechanism of monoacylglycerol lipase (MGL) inactivation

Karageorgos, I. L. (2012) · doi:10.17760/d20002973

Synergistic inhibition of cyclooxygenases and monoacylglycerol lipase in neuropathic pain

Crowe, M. S. (2014) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.515

Genetic pain loss disorders

(2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00375-5

Roles of FABPs on endocannabinoid transport and metabolism

Duttaroy, A. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95700-7.00029-2

Endocannabinoids in pain modulation

Chapman, V., & Woodhams, S. G. (2025) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-443-13908-6.00010-4

Endocannabinoid Modulation of Spatial Memory in Aversively and Appetitively Motivated Barnes Maze Tasks

Harloe, J. P. (2008) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/3826-5762

Sensing Mechanisms of GPCR- and OBP-Based Biosensors for Addictive Drug Detection

Wong, L. S., Zhang, X., Xia, Y., Tang, X., Guo, H., Zhang, H., Wang, P., Xu, B., & Wang, P. (2026) · Chemosensors · doi:10.3390/chemosensors14100225

BindingDB Entry 50042995: TBA

BindingDB (2014) · UC San Diego · doi:10.7270/q21r6rwj

A pro-nociceptive phenotype unmasked in mice lacking fatty-acid amide hydrolase

Carey, L. M., Slivicki, R. A., Leishman, E., Cornett, B., Mackie, K., Bradshaw, H. B., & Hohmann, A. G. (2016) · Molecular Pain · doi:10.1177/1744806916649192 · Cited by 53

Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

Cravatt, B. F., Demarest, K., Patricelli, M. P., Bracey, M. H., Giang, D. K., Martin, B. R., & Lichtman, A. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161191698 · Cited by 1,310

Targeting Fatty Acid Amide Hydrolase (FAAH) to Treat Pain and Inflammation

Schlosburg, J. E., Kinsey, S. G., & Lichtman, A. H. (2009) · The AAPS Journal · doi:10.1208/s12248-008-9075-y · Cited by 169

Short communication Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB 1 receptors

Wise, L. E., Shelton, C. C., Cravatt, B. F., Martin, B. R., & Lichtman, A. H. (2007)

Fatty acid amide hydrolase inhibition enhances the anti-allodynic actions of endocannabinoids in a model of acute pain adapted for the mouse

Palmer, J. A., Higuera, E. S., Chang, L., & Chaplan, S. R. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.04.047 · Cited by 26